BIO26-047: LYZ Is a Potential Target in Preventing Progression of Chronic Gastritis to Gastric Cancer and Possibly Regulated by Hederagenin

Affiliations

• ¹ 1Department of Spleen-Stomach Diseases, Guangdong Provincial Hospital of Chinese Medicine Hainan, Haikou, Hainan, China.
• ² 2Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
• ³ 3Guang'anmen Hospital, Chinese Academy of Traditional Chinese Medicine, Beijing, China.
• ⁴ 4Beijing institute of Traditional Chinese Medicine, Beijing University of Traditional Chinese Medicine, Beijing, China.
• ⁵ 5Geriatric Research, Education and Clinical Center, VA Palo Alto Health Care System, Palo Alto, CA.
• ⁶ 6LKS Faculty of Medicine, the University of Hong Kong, Hong Kong, China.
• ⁷ 7Department of Hepatobiliary Diseases, The First Affiliated Hospital of Guangzhou, University of Chinese Medicine, State Key Laboratory of Traditional Chinese Medicine Syndrome, Guangzhou, Guangdong, China.
• ⁸ 8Department of Medicine, Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA.
• ⁹ 9Lingnan Institute of Spleen and Stomach Diseases, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.